More recently, an elevated expression of PD-L1 was associated with aggressive tumor features, but nonetheless correlated with better response to chemotherapy, which suggested that an exhausted immune environment might play a role in therapy response [14,21,22]. The gene discussed is CD274; the disease is neoplasm.